0001702453-19-000004.txt : 20191120 0001702453-19-000004.hdr.sgml : 20191120 20191120100517 ACCESSION NUMBER: 0001702453-19-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191120 DATE AS OF CHANGE: 20191120 EFFECTIVENESS DATE: 20191120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cardurion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001702453 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-353793 FILM NUMBER: 191233267 BUSINESS ADDRESS: STREET 1: ONE LINCOLN STREET CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 617-996-1433 MAIL ADDRESS: STREET 1: ONE LINCOLN STREET CITY: BOSTON STATE: MA ZIP: 02111 FORMER COMPANY: FORMER CONFORMED NAME: Cardurion Pharmaceuticals, LLC DATE OF NAME CHANGE: 20170329 D 1 primary_doc.xml X0708 D LIVE 0001702453 Cardurion Pharmaceuticals, Inc. ONE LINCOLN STREET BOSTON MA MASSACHUSETTS 02111 617-996-1433 DELAWARE Cardurion Pharmaceuticals, LLC Corporation true 2017 Michael Mendelsohn c/o Cardurion Pharmaceuticals, Inc. One Lincoln Street Boston MA MASSACHUSETTS 02111 Executive Officer Director Kenneth Novack c/o Cardurion Pharmaceuticals, Inc. One Lincoln Street Boston MA MASSACHUSETTS 02111 Director Amy Schulman c/o Cardurion Pharmaceuticals, Inc. One Lincoln Street Boston MA MASSACHUSETTS 02111 Director Jeb Keiper c/o Cardurion Pharmaceuticals, Inc. One Lincoln Street Boston MA MASSACHUSETTS 02111 Director Biotechnology Decline to Disclose 06b false 2019-11-05 false true false 0 10000000 10000000 0 false 2 0 0 0 false Cardurion Pharmaceuticals, Inc. /s/ Michael Mendelsohn Michael Mendelsohn Chief Executive Officer 2019-11-20